Skip to main content
VulnerabilityPublished Updated

CVE-2026-33843: Microsoft Entra · Authentication Bypass Using an Alternate Path or Channel

Affects Microsoft EntraSource CVE Database V5

0

Not known to be exploited · CVSS 9.1 Critical · patch available : patch Microsoft Entra as a priority.

Data as of 26 Oct 2026, 09:16 UTC

CVSS 3.1 base score
9.1Critical
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.4% chance of exploitation in 30 days – higher than 40% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 22 May 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
MicrosoftMicrosoft EntraAffected
  • =-
Fixed in–

AI-suggested

Microsoft manages remediation for this cloud-hosted service and has made a patch available. Users of Microsoft Entra (Azure AD B2C) should ensure their service is updated according to the official Microsoft advisory at https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-33843. Since this is a cloud service, remediation is typically handled by Microsoft, and customers should verify their environments are receiving the latest updates.

Description

Authentication bypass using an alternate path or channel in Microsoft Azure Active Directory B2C allows an unauthorized attacker to elevate privileges over a network.

References

Community reviews

Loading reviews…